Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Interval Variation and Dosage in Preoperative Bevacizumab and Ziv-Aflibercept Administration in Proliferative Diabetic Retinopathy Undergoing Vitrectomy

NCT02590094 is registered in ClinicalTrials.gov with Panhandle Eye Group, LLP as lead sponsor.

NCT NCT02590094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02590094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Interval Variation and Dosage in Preoperative Bevacizumab and Ziv-Aflibercept Administration in Proliferative Diabetic Retinopathy Undergoing Vitrectomy
Lead sponsor
Panhandle Eye Group, LLP
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2015
Completion date
January 4, 2019
Enrollment
568 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy